O'Connor, O. A., Pro, B., Pinter-Brown, L., Bartlett, N., Popplewell, L., Coiffier, B., . . . Horwitz, S. (2011). Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: Results from the pivotal PROPEL study. Journal of clinical oncology, 29(9), 1182. https://doi.org/10.1200/JCO.2010.29.9024
Chicago-Zitierstil (17. Ausg.)O'Connor, Owen A., et al. "Pralatrexate in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: Results from the Pivotal PROPEL Study." Journal of Clinical Oncology 29, no. 9 (2011): 1182. https://doi.org/10.1200/JCO.2010.29.9024.
MLA-Zitierstil (9. Ausg.)O'Connor, Owen A., et al. "Pralatrexate in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: Results from the Pivotal PROPEL Study." Journal of Clinical Oncology, vol. 29, no. 9, 2011, p. 1182, https://doi.org/10.1200/JCO.2010.29.9024.